Prestige Consumer Healthcare PBH Share Repurchase Program, Authorized, Amount
Share Repurchase Program, Authorized, Amount at other companies
Other financials
Where this comes from
Reported directly by Prestige Consumer Healthcare in its filing.
Tagged under the XBRL concept srt:StockRepurchaseProgramAuthorizedAmount1.
The source filing: Prestige Consumer Healthcare’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:15 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001295947-26-000042
On May 6, 2024, the Company's Board of Directors authorized the repurchase of up to $300.0 million of the Company's issued and outstanding common stock. Under the authorization, the Company may purchase common stock utilizing open market transactions, transactions structured through investment banking institutions, in privately-negotiated transactions, by direct purchases of common stock or a combination of the foregoing in compliance with the applicable rules and regulations of the U.S. Securities and Exchange Commission. At June 30, 2026, there was $92.2 million remaining to be purchased under the repurchase program.
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Prestige Consumer Healthcare's share repurchase program, authorized, amount?
- Prestige Consumer Healthcare (PBH) reported share repurchase program, authorized, amount of $300M in Q2 2024.
- What does share repurchase program, authorized, amount mean?
- Share Repurchase Program, Authorized, Amount
Ask your AI about Prestige Consumer Healthcare's share repurchase program, authorized, amount.
Connect your AI assistant and compare it to peers, right in your chat.
